Back to search

Boston University

The role of glucose metabolism in the etiology of Alzheimer’s disease and its implications in treatment

Abstract

dc:description.abstract

Alzheimer’s Disease is a particularly vicious illness, with currently no preventative or curative treatment available. This paper focuses on how impairments in glucose metabolism and insulin signaling contribute to the disease process and further, on potential treatment options that target these specific dysfunctional processes in hopes of finding an effective cure or prevention therapy. Glucose hypometabolism presents years prior to the clinical symptoms of Alzheimer’s Disease and promotes the accumulation of Aβ, oxidative stress, and mitochondrial dysfunction. Additionally, a downregulation of GLUTs, particularly GLUT1 and GLUT3 also serves to decrease neural glucose uptake as well as to escalate glucose hypometabolism. Moreover, insulin resistance promotes tau hyperphosphorylation and extracellular aggregation of Aβ42, contributing to the Alzheimer’s Disease pathology. Due to the central role of insulin and glucose neural dysfunction to Alzheimer’s Disease, these processes pose as strong potential targets for much needed Alzheimer’s Disease curative and preventative therapy. Specifically, antioxidants and antidiabetics such as Metformin, thiazolidinediones, sulfonylureas, incretins, and intranasal insulin have shown some potential as future treatment options for Alzheimer’s Disease but require further investigation. Some non-pharmacological approaches, such as the ketogenic diet, have also been proposed as viable treatment options and work via their effects on glucose and insulin pathways. Dysfunctional glucose metabolism and insulin resistance are incredibly important in the progression of the Alzheimer’s Disease stages and as such, present as viable potential targets of future drug therapies.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Safransky, Michelle
Advisors dc:contributor.advisor
  • Trinkaus-Randall, Vickery
  • Offner, Gwynneth D.

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/43882

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Safransky, Michelle. The role of glucose metabolism in the etiology of Alzheimer’s disease and its implications in treatment. masters thesis, Boston University, 2021. https://hdl.handle.net/2144/43882